1069 — China Health Technology Holding Income Statement
0.000.00%
Last trade - 00:00- HK$40.38m
- HK$160.21m
- CNY47.61m
Annual income statement for China Health Technology Holding, fiscal year end - June 30th, CNY millions except per share, conversion factor applied.
2019 December 31st | R2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 18 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 54.3 | 0 | 6.76 | 58.7 | 47.6 |
| Cost of Revenue | |||||
| Gross Profit | 34.8 | 0 | 0 | 11.5 | 1.9 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 372 | 513 | 5.92 | 56.4 | -156 |
| Operating Profit | -317 | -513 | 0.836 | 2.31 | 203 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -340 | -547 | -20.4 | -9.37 | 200 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -340 | -547 | -20.4 | -10.8 | 200 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -340 | -554 | -18.9 | -10.8 | 200 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -340 | -554 | -18.9 | -10.8 | 200 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -2.79 | -0.564 | -0.297 | -0.322 | 0.08 |
| Dividends per Share |